Abstract.
Discussion of differences between recommended guidelines and clinical practice is very useful in medicine. The use of a computerized database of all prescriptions of antiparkinsonian drugs enabled us to perform an epidemiological population-based study with low cost and in a relatively short time. We have identified 2 827 parkinsonian patients in November 2000 and estimate the number of patients taking dopaminoagonists aged >75 years, antidepressive drugs, and atypical neuroleptics.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vanacore, N., Bianchi, C., Da Cas, R. et al. Use of antiparkinsonian drugs in the Umbria Region. Neurol Sci 24, 221–222 (2003). https://doi.org/10.1007/s10072-003-0140-0
Issue Date:
DOI: https://doi.org/10.1007/s10072-003-0140-0